학술논문
1429P Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S1069-S1069
Subject
Language
ISSN
0923-7534